Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesis

Hepatobiliary and Pancreatic Diseases International

Volumn 8, Issue 5, 2009, Pages 504-509

  Wu, Wei ^a   Yao, Deng Fu ^a   Qiu, Li Wei ^a   Sai, Wen Li ^a   Shen, Jun Jun ^a   Yu, Hong Bo ^a   Wu, Xin Hua ^a   Li, Yue Ming ^a   Wang, Yi Lang ^a   Gu, Wen Jing ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Immunohistochemistry; Nested polymerase chain reaction; NF B mRNA; Nuclear factor kappa B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STAGING; CELL DEGENERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER LEVEL; MALE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; SIGNAL TRANSDUCTION;

2-ACETYLAMINOFLUORENE; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HEPATOCYTES; LIVER; LIVER NEOPLASMS; MALE; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 70350294120     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Wang J, Tokoro T, Higa S, Kitajima I. Anti-inflammatory effect of pitavastatin on NF-kappaB activated by TNF-alpha in hepatocellular carcinoma cells. Biol Pharm Bull 2006;29:634-639.
2. Lupberger J, Hildt E. Hepatitis B virus-induced oncogenesis. World J Gastroenterol 2007;13:74-81.
3. Amarapurkar AD, Vibhav, Kim V. Angiogenesis in liver cirrhosis and hepatocellular carcinoma. Indian J Pathol Microbiol 2008;51:323-328.
4. Zhu P, Tan D, Peng Z, Liu F, Song L. Polymorphism analyses of hepatitis B virus X gene in hepatocellular carcinoma patients from southern China. Acta Biochim Biophys Sin (Shanghai) 2007;39:265-272. (Pubitemid 46625308)
5. Guo LL, Xiao S, Guo Y. Activation of transcription factors NF-kappaB and AP-1 and their relations with apoptosis associated-proteins in hepatocellular carcinoma. World J Gastroenterol 2005;11:3860-13685 (Pubitemid 41025238)
6. Liu X, Wang L, Zhang S, Lin J, Zhang S, Feitelson MA, et al. Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses. Carcinogenesis 2008;29:1207-1214. (Pubitemid 351958700)
7. Park SG, Lee T, Kang HY, Park K, Cho KH, Jung G. The influence of the signal dynamics of activated form of IKK on NF-kappaB and anti-apoptotic gene expressions: a systems biology approach. FEBS Lett 2006;580:822-830. (Pubitemid 43152301)
8. Lee SH, Park SG, Lim SO, Jung G. The hepatitis B virus X protein up-regulates lymphotoxin alpha expression in hepatocytes. Biochim Biophys Acta 2005;1741:75-84. (Pubitemid 40824992)
9. Allen CT, Ricker JL, Chen Z, Van Waes C. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck. Head Neck 2007;29:959-971.
10. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006;441:431-436. (Pubitemid 44050137)
11. Kim HJ, Hawke N, Baldwin AS. NF-kappaB and IKK as therapeutic targets in cancer. Cell Death Differ 2006;13:738-747.
12. Van Waes C, Chang AA, Lebowitz PF, Druzgal CH, Chen Z, Elsayed YA, et al. Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2005;63:1400-1412. (Pubitemid 41628035)
13. Cheong R, Hoffmann A, Levchenko A. Understanding NF-kappaB signaling via mathematical modeling. Mol Syst Biol 2008;4:192.
14. Qin JM, Wan XW, Zeng JZ, Wu MC. Effect of Sirpalpha1 on the expression of nuclear factor-kappa B in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2007;6:276-283. (Pubitemid 46925249)
15. Hoffmann A, Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol Rev 2006;210:171-186.
16. Sriwijitkamol A, Christ-Roberts C, Berria R, Eagan P, Pratipanawatr T, DeFronzo RA, et al. Reduced skeletal muscle inhibitor of kappaB beta content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise training. Diabetes 2006;55:760-767. (Pubitemid 43343233)
17. Duan J, Friedman J, Nottingham L, Chen Z, Ara G, Van Waes C. Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101. Mol Cancer Ther 2007;6:37-50. (Pubitemid 46206667)
18. Ozaki I, Zhang H, Mizuta T, Ide Y, Eguchi Y, Yasutake T, et al. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation. Clin Cancer Res 2007;13:2236-2245. (Pubitemid 46649893)
19. Yu M, Yeh J, Van Waes C. Protein kinase casein kinase 2 mediates inhibitor-kappaB kinase and aberrant nuclear factor-kappaB activation by serum factor(s) in head and neck squamous carcinoma cells. Cancer Res 2006;66:6722-6731. (Pubitemid 44085630)
20. Piccagli L, Fabbri E, Borgatti M, Bezzerri V, Mancini I, Nicolis E, et al. Docking of molecules identified in bioactive medicinal plants extracts into the p50 NF-kappaB transcription factor: correlation with inhibition of NF-kappaB/DNA interactions and inhibitory effects on IL-8 gene expression. BMC Struct Biol 2008;8:38.
21. Karin M. NF-kappaB and cancer: mechanisms and targets. Mol Carcinog 2006;45:355-361.
22. Van Waes C. Nuclear factor-kappaB in development, prevention, and therapy of cancer. Clin Cancer Res 2007;13:1076-1082.
23. Yan B, Chen G, Saigal K, Yang X, Jensen ST, Van Waes C, et al. Systems biology-defined NF-kappaB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 status. Genome Biol 2008;9:R53. (Pubitemid 351959562)
24. Grosjean J, Kiriakidis S, Reilly K, Feldmann M, Paleolog E. Vascular endothelial growth factor signalling in endothelial cell survival: a role for NFkappaB. Biochem Biophys Res Commun 2006;340:984-994. (Pubitemid 43053924)